Israpafant
- Product NameIsrapafant
- CAS117279-73-9
- CBNumberCB51178985
- MFC28H29ClN4S
- MW489.07
- MDL NumberMFCD00873428
- MOL File117279-73-9.mol
Chemical Properties
| Melting point: | 129.5-131.5° |
Israpafant Chemical Properties,Usage,Production
Uses
Israpafant (Y-24180) is a potent, selective and long-acting platelet activation factor (PAF) receptor antagonist with IC50s of 0.84 nM and 3.84 nM against PAF-induced human and rabbit platelet aggregation, respectively. Israpafant stimulates both extracellular Ca2+ influx and intracellular Ca2+ release in prostate cancer cells. Israpafant suppresses the allergic cutaneous reactions including eosinophilia, cytokine production, edema and erythema in mice[1][2].References
[1] Takehara S, et al. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. Prostaglandins. 1990 Dec;40(6):571-83. DOI:10.1016/0090-6980(90)90002-d[2] Jan C R, Chao Y Y. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells. Cellular signalling, 2004, 16(8): 959-965.
Israpafant Suppliers
Global(10)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | 32430 | 58 | ||
| 15870833005 | 2232044025@qq.com | 8198 | 58 | ||
| +86-400-002-6226 13028896684; | sales@rrkchem.com | 57330 | 58 | ||
| +44 (0)1223 859 353 | info@biorbyt.com | 6478 | 58 | ||
| 021-64340559 | xinyu_shi@jwypharmlab.com.cn | 11999 | 58 | ||
| 4008200310 15002144251 | marketing@tsbiochem.com | 24951 | 58 | ||
| 021-58447131 13564518121 | doncunbiosci@gmail.com | 618 | 58 | ||
| 021-20432219 13918097649 | li_jinfei@acblock-lab.com | 9969 | 58 | ||
| 13440048448 | sales@lanospharma.com | 6284 | 56 |